Methotrexate in Dogs & Cats
Generic: Methotrexate
Methotrexate is a potent antimetabolite medication primarily used in veterinary oncology as a chemotherapy agent to slow the growth of rapidly dividing cells in various cancers.
This medication is intended for dogs and cats.
Overview
Methotrexate is an antifolate chemotherapy drug that functions as a cornerstone in the treatment of specific malignant neoplasms in dogs and cats. Unlike alkylating agents such as Melphalan or Chlorambucil, which damage DNA directly, methotrexate acts as a cycle-specific drug that targets cells in the synthesis phase of the cell cycle. Its clinical use is typically reserved for specialized veterinary oncology protocols where high efficacy is required to manage aggressive cellular proliferation, often in conjunction with other chemotherapeutic agents like Vincristine or Doxorubicin. In veterinary practice, methotrexate is employed to manage complex disease states where standard therapy might be insufficient. While some oncologists might compare its utility to agents like Hydroxyurea or Cytarabine, the specific molecular target of methotrexate provides a unique mechanism for inducing apoptosis in neoplastic cells. Veterinarians must exercise extreme caution during administration due to the drug's narrow therapeutic index and the potential for significant systemic toxicity. Comprehensive monitoring of hematologic parameters and organ function is essential throughout the duration of treatment. Because it is highly potent, clinicians often utilize it in maintenance therapy protocols or as part of a multi-drug regimen designed to minimize resistance. By interfering with folate metabolism, the drug effectively halts the production of essential building blocks required for DNA synthesis, leading to the programmed death of malignant cells and potentially providing palliative benefits for pets with advanced stage disease.
What It Treats
- Lymphoma: Often used as a rescue or maintenance therapy in relapsed cases.
- Osteosarcoma: Utilized in specific protocols to prevent or delay metastasis.
- Central Nervous System Neoplasia: Its ability to influence cell turnover makes it a consideration for certain brain tumors.
- Immune-mediated diseases: Occasionally used off-label in refractory cases of severe autoimmune skin or joint conditions.
How It Works
Methotrexate acts as a folic acid antagonist. It binds to the enzyme dihydrofolate reductase (DHFR), which is responsible for converting dihydrofolate into its active form, tetrahydrofolate. Tetrahydrofolate is a critical co-factor in the synthesis of thymidine and purines, which are the fundamental building blocks of DNA. By inhibiting this enzyme, the drug effectively induces 'thymineless death' in rapidly dividing cells, preventing them from replicating their genetic material and proceeding through the cell cycle. Because cancer cells typically divide at a much faster rate than normal healthy tissues, they are disproportionately affected by this interruption of folate metabolism.
Dosage
Methotrexate dosage is highly variable and depends on the specific cancer protocol, the patient's body surface area, and their overall organ function. There is no standard dose for home administration, and it must be calculated precisely by a veterinary oncologist. Owners should never adjust the dose, as small variations can lead to severe, life-threatening toxicity.
Administration
Methotrexate can be administered orally (as tablets) or via intravenous injection depending on the institutional protocol. When handling the medication, extreme care is required; it is a cytotoxic agent, and owners should wear gloves if administering oral doses at home. Do not crush or split tablets, as this can lead to exposure to drug dust, which is hazardous to humans.
Storage
Store methotrexate at room temperature, away from moisture, light, and direct heat. Keep the medication in its original, child-proof, and pet-proof container, and store it in an area inaccessible to other household members and pets. Cytotoxic medications should be kept separate from other household pills to prevent accidental ingestion.
Contraindications
Methotrexate should not be used in animals with pre-existing bone marrow suppression, significant renal insufficiency, or active hepatic disease, as the drug is cleared through these organs and can exacerbate underlying failure. It is also contraindicated in pregnant or lactating animals due to its known teratogenic and abortifacient effects. In patients with active infections or severe dehydration, the drug must be withheld until the patient is stabilized.
Interactions
Methotrexate is highly susceptible to interactions with non-steroidal anti-inflammatory drugs (NSAIDs), such as aspirin or ibuprofen, which can decrease the renal clearance of methotrexate, leading to dangerous systemic concentrations. Furthermore, certain antibiotics like trimethoprim-sulfa can displace methotrexate from plasma proteins or inhibit its excretion, significantly increasing the risk of toxicity. Clinicians must be alerted to all concurrent medications, including supplements, before initiating therapy.
Side Effects
- Gastrointestinal upset (vomiting, diarrhea, anorexia)
- Myelosuppression (low white blood cell counts, anemia, low platelets)
- Hepatotoxicity (liver enzyme elevation or injury)
- Nephrotoxicity (kidney damage)
- Stomatitis or oral ulcerations
- Dermatologic reactions
Sources & References
Frequently Asked Questions
This information is educational only and not a substitute for professional veterinary advice. Always consult a licensed veterinarian before starting or changing any medication.